The clinical effects and mechanism of action of ranibizumab in treating myopic choroidal neovascularization. [PDF]
Gu W, Wang Z, Peng D, Gu Y.
europepmc +1 more source
Myopic choroidal neovascularization with dilated choroid vessels is prone to progression into subretinal fibrosis following anti-vascular endothelial growth factor therapy: a retrospective study. [PDF]
She X +7 more
europepmc +1 more source
Systemic Oxidative Stress Level as a Pathological and Prognostic Factor in Myopic Choroidal Neovascularization. [PDF]
Wang J +5 more
europepmc +1 more source
One-Year Outcome of Intravitreal Injection of Ranibizumab Biosimilar for Myopic Choroidal Neovascularization in Japanese Patients. [PDF]
Tomita M +7 more
europepmc +1 more source
Baseline characteristics of myopic choroidal neovascularization in patients above 50 years old and prognostic factors after intravitreal conbercept treatment. [PDF]
Wang HY +7 more
europepmc +1 more source
Treatment of myopic choroidal neovascularization: a network meta-analysis and review. [PDF]
Glachs L +7 more
europepmc +1 more source
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real-world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization. [PDF]
Nie X, Wang Y, Yi H, Qiao Y.
europepmc +1 more source
Optical Coherence Tomography Angiography-Based Quantitative Assessment of Morphologic Changes in Active Myopic Choroidal Neovascularization During Anti-vascular Endothelial Growth Factor Therapy. [PDF]
Wang Y +15 more
europepmc +1 more source
Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab. [PDF]
Rico S +4 more
europepmc +1 more source
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy. [PDF]
She X +10 more
europepmc +1 more source

